Reduction of immunosuppressant therapy requirement in heart transplantation by calcitriol

Transplantation

Volumn 75, Issue 12, 2003, Pages 2133-2134

  Kathryn Briffa, N ^a   Keogh, Anne M ^b   Sambrook, Philip N ^c   Eisman, John A ^a  

^a GARVAN INSTITUTE OF MEDICAL RESEARCH   (Australia)

^b ST VINCENT S HOSPITAL   (Australia)

^c UNIVERSITY OF SYDNEY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

CALCITRIOL; CALCIUM; CREATININE; CYCLOSPORIN; PREDNISOLONE;

ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORTICOSTEROID INDUCED OSTEOPOROSIS; CREATININE BLOOD LEVEL; DOSE RESPONSE; DOUBLE BLIND PROCEDURE; DRUG INDICATION; DRUG MECHANISM; DRUG POTENTIATION; FEMALE; FOLLOW UP; GRAFT REJECTION; GRAFT SURVIVAL; HEART TRANSPLANTATION; HUMAN; IMMUNOMODULATION; IMMUNOSUPPRESSIVE TREATMENT; INFECTION; MAJOR CLINICAL STUDY; MALE; OSTEOLYSIS; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SIDE EFFECT; TIME SERIES ANALYSIS;

BONE DENSITY; CALCITRIOL; CALCIUM; CREATININE; CYCLOSPORINE; DOSE-RESPONSE RELATIONSHIP, DRUG; HEART TRANSPLANTATION; HUMANS; IMMUNOSUPPRESSIVE AGENTS; INFECTION; POSTOPERATIVE COMPLICATIONS; PREDNISOLONE; RETROSPECTIVE STUDIES;

EID: 0038789104     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.TP.0000065179.06731.99     Document Type: Article

References (4)

1. Sambrook P, Henderson NK, Keogh A, et al. Effect of calcitriol on bone loss after cardiac or lung transplantation. J Bone Miner Res 2000; 15: 1818.
2. Lemire JM. Immunomodulatory role of 1, 25-dihydroxyvitamin D3. J Cell Biochem 1992; 49: 26.
3. Hullett DA, Cantorna MT, Redaelli C, et al. Prolongation of allograft survival by 1, 23-dihydroxyvitamin D3. Transplantation 1998; 66: 824.
4. Henderson K, Eisman J, Keogh A, et al. Protective effect of short-term calcitriol or cyclical etidronate on bone loss after cardiac or lung transplantation. J Bone Miner Res 2001; 16: 556.